Company news
Oncology Pharma Inc. news in 2019
Oncology Pharma Inc.'s news releases, calls and decks from 2019, newest first.
CORRECTION: Oncology Pharma Receives LOI for Financing for US$ 38.4M from SCP Investment Partners, Ltd
December 26, 2019
Oncology Pharma Receives LOI for Financing for US$ 38.4M from SCP Partners Ltd
December 23, 2019
Oncology Pharma Signs Letter of Intent to Acquire a Significant Stake in Diagnomics, Inc.
December 11, 2019
Oncology Pharma and Ribera Solutions Signed a Licensing Agreement for the Use of Ribera's Clinical Trials Platform, Connect2Med
November 6, 2019
Oncology Pharma Appoints Dr. Vijay Mahant as the Chief Scientific Officer and Chief Operating Officer
October 15, 2019
Oncology Pharma Elects Dr. Stefan Gruenwald (MD, PhD) to its Board of Directors
October 8, 2019
Kalos Therapeutics, Inc., Oncology Pharmaceuticals and NanoSmart Pharmaceuticals, Inc., Combination Therapy Offers the Potential of a Safer and More Effective Approach to a Wide Variety of Cancer Treatments
September 30, 2019
Update: Oncology Pharma Signed a Letter of Intent with Kalos Therapeutics for an Exclusive World-Wide License and Co-Development of Its Broad-Spectrum Anti-Cancer Drug, KTH 222
August 19, 2019
Oncology Pharma Signed a Letter of Intent with Kalos Therapeutics for an Exclusive World-Wide Licence and Co-Devlopent of Its Broad-Spectrum Anti-Cancer Drug, KTH 222
August 19, 2019
Oncology Pharma Appoints Stefan Gruenwald (MD. Ph.D) as an Advisor on its Advisory Board
July 15, 2019
SourcingLink.net Announces Corporate Name Change to Oncology Pharma, Inc.
June 17, 2019
Veterinary Oncology Licensing Agreement Signed Between SourcingLink.net and NanoSmart Pharmaceuticals, Inc.
April 3, 2019
SourcingLink.net Enters into an Exclusive Worldwide Licensing Agreement with NanoSmart Pharmaceuticals for Anti-Nuclear Antibody (ANA)-Targeted Doxorubicin Formulations to Treat Cancer
March 25, 2019
SourcingLink.net Signs a Letter of Intent with NanoSmart Pharmaceuticals, Inc. for a Licensee and Co-Development Collaboration of NanoSmart's Proprietary Targeted Drug Delivery System for Cancer Drugs
February 26, 2019
SourcingLink.net to Investigate the Potential of Combining its Novel Autologous Immune-Therapy with Synergistic Oncology Therapies
February 12, 2019
SourcingLink.net to Leverage Pharmacogenomics in Its Oncology Therapy Development and Clinical Trial Program
February 5, 2019
SourcingLink.net Plans to Use 'Game Changing' Diagnostic Tool in its R&D and Beyond
January 28, 2019
SourcingLink.net Licenses an Immune-Cell Therapy in Oncology from Tulynode Biosciences, Inc.
January 22, 2019